The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
Abstract
OBJECTIVE: To determine indications for the use of postmastectomy radiotherapy (PMRT) for patients with invasive breast cancer with involved axil-lary lymph nodes or locally advanced disease who receive systemic therapy. These guidelines are intended for use in the care of patients outside of clinical trials. POTENTIAL INTERVENTION: The benefits and risks of PMRT in such patients, as well as subgroups of these patients, were considered. The details of the PMRT technique were also evaluated. OUTCOMES: The outcomes considered included freedom from local-regional recurrence, survival (disease-free and overall), and long-term toxicity. EVIDENCE: An expert multidisciplinary panel reviewed pertinent information from the published literature through July 2000; certain investigators were contacted for more recent and, in some cases, unpublished information. A computerized search was performed of MEDLINE data; directed searches based on the bibliographies of primary articles were also performed. VALUES: Levels of evidence and guideline grades were assigned by the Panel using standard criteria. A “recommendation” was made when level I or II evidence was available and there was consensus as to its meaning. A “suggestion” was made based on level III, IV, or V evidence and there was consensus as to its meaning. Areas of clinical importance were pointed out where guidelines could not be formulated due to insufficient evidence or lack of consensus. RECOMMENDATIONS: The recommendations, suggestions, and expert opinions of the Panel are described in this article. VALIDATION: Seven outside reviewers, the American Society of Clinical Oncology (ASCO) Health Services Research Committee members, and the ASCO Board of Directors reviewed this document.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolerance of normal tissue to therapeutic irradiation
Emami, B., Lyman, J., Brown, A., Cola, L., Goitein, M., Munzenrider, J. E., Shank, B., Solin, L. J., & Wesson, M. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90171-y · Cited by 4,488
Self-citationTamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Overgaard, M., Hansen, P. S., Overgaard, J., Rose, C., Andersson, M., Bach, F., Kjaer, M., Gadeberg, C. C., Mouridsen, H. T., Jensen, M.-B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371401 · Cited by 2,554
Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer
Ragaz, J., Jackson, S. M., Le, N., Plenderleith, I. H., Spinelli, J. J., Basco, V. E., Wilson, K. S., Knowling, M. A., Coppin, C. M. L., Paradis, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371402 · Cited by 1,745
Overgaard, M., Jensen, M.-B., Overgaard, J., Hansen, P. S., Rose, C., Andersson, M., Kamby, C., Kjaer, M., Gadeberg, C. C., Rasmussen, B. B., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09201-0 · Cited by 1,602
Veronesi, U., Saccozzi, R., Del Vecchio, M., Banfi, A., Clemente, C., De Lena, M., Gallus, G., Greco, M., Luini, A., Marubini, E., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107023050102 · Cited by 1,599
Fisher, B., Redmond, C., Fisher, E. R., Bauer, M., Wolmark, N., Wickerham, D. L., Deutsch, M., Montague, E., Margolese, R., & Foster, R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121102 · Cited by 1,376
Rules of Evidence and Clinical Recommendations on the Use of Antithrombotic Agents
Sackett, D. L. (1989) · Chest · doi:10.1378/chest.95.2_supplement.2s · Cited by 1,368
Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials
(1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332202 · Cited by 1,012
Incidence of Cancer in 161 Families Affected by Ataxia–Telangiectasia
Swift, M., Morrell, D., Massey, R. B., & Chase, C. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112263252602 · Cited by 939
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
Slevin, M. L., Stubbs, L., Plant, H. J., Wilson, P., Gregory, W. M., Armes, P. J., & Downer, S. M. (1990) · BMJ · doi:10.1136/bmj.300.6737.1458 · Cited by 753
Fisher, B., Brown, A. M., Dimitrov, N. V., Poisson, R., Redmond, C., Margolese, R. G., Bowman, D., Wolmark, N., Wickerham, D. L., & Kardinal, C. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1483 · Cited by 620
Levine, M. N., Bramwell, V. H., Pritchard, K. I., Norris, B. D., Shepherd, L. E., Abu-Zahra, H., Findlay, B., Warr, D., Bowman, D., Myles, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2651 · Cited by 617
Arriagada, R., Lê, M. G., Rochard, F., & Contesso, G. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1558 · Cited by 612
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
Wood, W. C., Budman, D. R., Korzun, A. H., Cooper, M. R., Younger, J., Hart, R. D., Moore, A., Ellerton, J. A., Norton, L., Ferree, C. R., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301801 · Cited by 577
Pulmonary Effects of Radiation Therapy
GROSS, N. J. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-1-81 · Cited by 563
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
(1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310226 · Cited by 556
Does Locoregional Radiation Therapy Improve Survival in Breast Cancer? A Meta-Analysis
Whelan, T. J., Julian, J., Wright, J., Jadad, A. R., & Levine, M. L. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1220 · Cited by 507
Self-citationPeters, W. P., Ross, M., Vredenburgh, J. J., Meisenberg, B., Marks, L. B., Winer, E., Kurtzberg, J., Bast, R. C., Jones, R., & Shpall, E. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1132 · Cited by 501
Veronesi, U., Banfi, A., Salvadori, B., Luini, A., Saccozzi, R., Zucali, R., Marubini, E., Del Vecchio, M., Boracchi, P., Marchini, S., et al. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90113-8 · Cited by 493
Pierce, S. M., Recht, A., Lingos, T. I., Abner, A., Vicini, F., Silver, B., Herzog, A., & Harris, J. R. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90895-o · Cited by 482
Self-citationRisk of Leukemia after Chemotherapy and Radiation Treatment for Breast Cancer
Curtis, R. E., Boice, J. D., Stovall, M., Bernstein, L., Greenberg, R. S., Flannery, J. T., Schwartz, A. G., Weyer, P., Moloney, W. C., & Hoover, R. N. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262605 · Cited by 446
Recht, A., Gray, R., Davidson, N. E., Fowble, B. L., Solin, L. J., Cummings, F. J., Falkson, G., Falkson, H. C., Taylor, S. G., & Tormey, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1689 · Cited by 440
Self-citationRecht, A., Come, S. E., Henderson, I. C., Gelman, R. S., Silver, B., Hayes, D. F., Shulman, L. N., & Harris, J. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342102 · Cited by 436
Self-citationCancer in the Contralateral Breast after Radiotherapy for Breast Cancer
Boice, J. D., Harvey, E. B., Blettner, M., Stovall, M., & Flannery, J. T. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203193261201 · Cited by 432
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.671 · Cited by 431
Scholl, S. M., Fourquet, A., Asselain, B., Pierga, J. Y., Vilcoq, J. R., Durand, J. C., Dorval, T., Palangié, T., Jouve, M., Beuzeboc, P., et al. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90537-1 · Cited by 424
Rutqvist, L. E., Lax, I., Fornander, T., & Johansson, H. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90784-f · Cited by 391
Larson, D., Weinstein, M., Goldberg, I., Silver, B., Recht, A., Cady, B., Silen, W., & Harris, J. R. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90280-4 · Cited by 374
Self-citationHøjris, I., Overgaard, M., Christensen, J. J., & Overgaard, J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02245-x · Cited by 350
Veronesi, U., Marubini, E., Mariani, L., Valagussa, P., & Zucali, R. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00133-1 · Cited by 345
Heterozygous ATM mutations do not contribute to early onset of breast cancer
FitzGerald, M. G., Bean, J. M., Hegde, S. R., Unsal, H., MacDonald, D. J., Harkin, D. P., Finkelstein, D. M., Isselbacher, K. J., & Haber, D. A. (1997) · Nature Genetics · doi:10.1038/ng0397-307 · Cited by 340
Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer
Athma, P., Rappaport, R., & Swift, M. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00328-7 · Cited by 330
Second cancer following cancer of the breast in Connecticut, 1935-82.
Eb, H., & Brinton, L. (1985) · PubMed · Cited by 312
Long-term risk of sarcoma following radiation treatment for breast cancer
Taghian, A., de Vathaire, F., Terrier, P., Le, M., Auquier, A., Mouriesse, H., Grimaud, E., Sarrazin, D., & Tubiana, M. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90783-z · Cited by 309
Fisher, B., Anderson, S., Wickerham, D. L., DeCillis, A., Dimitrov, N., Mamounas, E., Wolmark, N., Pugh, R., Atkins, J. N., Meyers, F. J., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1858 · Cited by 308
Paszat, L. F., Mackillop, W. J., Groome, P. A., Boyd, C., Schulze, K., & Holowaty, E. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2625 · Cited by 302
Fisher, B., Redmond, C., Legault-Poisson, S., Dimitrov, N. V., Brown, A. M., Wickerham, D. L., Wolmark, N., Margolese, R. G., Bowman, D., & Glass, A. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.6.1005 · Cited by 291
Radiotherapy-Related Lung Fibrosis Enhanced by Tamoxifen
Bentzen, S. M., Skoczylas, J. Z., Overgaard, M., & Overgaard, J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.13.918 · Cited by 281
Consensus statement on postmastectomy radiation therapy
Harris, J. R., Halpin-Murphy, P., McNeese, M., Mendenhall, N. P., Morrow, M., & Robert, N. J. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00096-6 · Cited by 277
Inefficacy of internal mammary nodes dissection in breast cancer surgery
Veronesi, U., & Valagussa, P. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<170::aid-cncr2820470128>3.0.co;2-c · Cited by 274
Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients.
Shapiro, C. L., Hardenbergh, P. H., Gelman, R., Blanks, D., Hauptman, P., Recht, A., Hayes, D. F., Harris, J., & Henderson, I. C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3493 · Cited by 264
Self-citationSurvey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy.
Ravdin, P. M., Siminoff, I. A., & Harvey, J. A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.515 · Cited by 262
Rutqvist, L., & Johansson, H. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.193 · Cited by 252
Paszat, L. F., Mackillop, W. J., Groome, P. A., Schulze, K., & Holowaty, E. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00412-x · Cited by 231
Conservation treatment of early breast cancer: Long term results and complications
Delouche, G., Bachelot, F., Premont, M., & Kurtz, J. M. (1987) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(87)90256-2 · Cited by 225
Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules
Powell, S., Cooke, J., & Parsons, C. (1990) · Radiotherapy and Oncology · doi:10.1016/0167-8140(90)90057-4 · Cited by 222
Rules of Evidence and Clinical Recommendations on the Use of Antithrombotic Agents
Cook, D. J., Guyatt, G. H., Laupacis, A., & Sackett, D. L. (1992) · Chest · doi:10.1378/chest.102.4_supplement.305s · Cited by 217
Fisher, B., Rockette, H., Fisher, E. R., Wickerham, D. L., Redmond, C., & Brown, A. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.12.1640 · Cited by 204
Fowble, B., Gray, R., Gilchrist, K., Goodman, R. L., Taylor, S., & Tormey, D. C. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.7.1107 · Cited by 202
Standards for breast-conservation treatment
Winchester, D. P., & Cox, J. D. (1992) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.42.3.134 · Cited by 188
Haybittle, J. L., Brinkley, D., Houghton, J., A'Hern, R. P., & Baum, M. (1989) · BMJ · doi:10.1136/bmj.298.6688.1611 · Cited by 188
Andersson, M., Storm, H. H., & Mouridsen, H. T. (1991) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/83.14.1013 · Cited by 169
Griem, K., Henderson, I. C., Gelman, R. S., Dm, A., Silver, B., Recht, A., Goodman, R. L., Hellmän, S., & Harris, J. R. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1546 · Cited by 147
Self-citationHankey, B. F., Curtis, R. E., Naughton, M. D., Boice, J. D., & Flannery, J. (1983) · PubMed · Cited by 132
Goldhirsch, A., Gelber, R. D., & Castiglione, M. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.1.89 · Cited by 128
Cardiac doses in post-operative breast irradiation
Fuller, S., Haybittle, J. L., Smith, R. E., et al. (1992) · Radiotherapy and Oncology · doi:10.1016/0167-8140(92)90190-6 · Cited by 123
Second primary cancers of the breast: Incidence and risk factors
Hislop, T. G., Elwood, M., Coldman, A. J., Spinelli, J. J., Worth, A. J., & Ellison, L. G. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.12 · Cited by 123
Diamandidou, E., Buzdar, A. U., Smith, T. L., Frye, D., Witjaksono, M. A., & Hortobágyi, G. N. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2722 · Cited by 122
Breast irradiation postlumpectomy: development and evaluation of a decision instrument.
Whelan, T. J., Levine, M. N., Gafni, A., Lukka, H. R., Mohide, E. A., Patel, M., & Streiner, D. L. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.4.847 · Cited by 119
Self-citationA clinical trial in the management of operable cancer of the breast
Langlands, A. O., Prescott, R. J., & Hamilton, T. (1980) · British journal of surgery · doi:10.1002/bjs.1800670304 · Cited by 114
Hayman, J. A., Fairclough, D. L., Harris, J. R., & Weeks, J. C. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1252 · Cited by 113
Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations
Gaffney, D. K., Brohet, R. M., Lewis, C. M., Holden, J. A., Buys, S. S., Neuhausen, S. L., Steele, L., Avizonis, V. N., Stewart, J. R., & Cannon‐Albright, L. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00023-1 · Cited by 109
Rutqvist, L. E., Liedberg, A., Hammar, N., & Dalberg, K. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00765-7 · Cited by 102
Pulmonary toxicity of antineoplastic therapy.
Kreisman, H., & Wolkove, N. (1992) · PubMed · Cited by 101
Respiratory Diseases from Hard Metal or Cobalt Exposure
Demedts, M., & Ceuppens, J. L. (1989) · CHEST Journal · doi:10.1378/chest.95.1.2 · Cited by 99
Risk of contralateral breast cancer in Denmark 1943-80
Storm, H. H., & Jensen, O. M. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.201 · Cited by 99
Pritchard, K. I., Paterson, A. H. G., Fine, S., Paul, N., Zee, B. C.-Y., Shepherd, L. E., Abu-Zahra, H., Ragaz, J., Knowling, M. A., Levine, M. N., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2302 · Cited by 94
Boccardo, F., RUBAGOTTI, A., Bruzzi, P., Cappellini, M. D., Isola, G., Nenci, I., PIFFANELLI, A., Scanni, A., Sismondi, P., & Santi, L. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.8.1310 · Cited by 94
Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer
Buzdar, A. U., Smith, T. L., Powell, K. C., et al. (1982) · Breast Cancer Research and Treatment · doi:10.1007/bf01806452 · Cited by 91
Vélez-García, E., Carpenter, J. T., Moore, M., Vogel, C. L., Marcial, V. A., Ketcham, A. S., Singh, K. P., Bass, D., Bartolucci, A. A., & Smalley, R. V. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90015-t · Cited by 90
Primary Breast Cancer Complications of Axillary Management
Yeoh, E. K., Denham, J. W., Davies, S., & Spittle, M. F. (1986) · Acta Radiologica Oncology · doi:10.3109/02841868609136386 · Cited by 86
Palda, V. A., Llewellyn‐Thomas, H. A., Mackenzie, R. G., Pritchard, K. I., & Naylor, C. D. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.10.3192 · Cited by 76
Bentzen, S. M., Overgaard, M., Thames, H. D., Christensen, J. J., & Overgaard, J. (1989) · International Journal of Radiation Biology · doi:10.1080/09553008914551941 · Cited by 76
Shayeghi, M., Seal, S., Regan, J., Collins, N., Barfoot, R., Rahman, N., Ashton, A., Moohan, M., Wooster, R., Owen, R., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.602 · Cited by 69
Boccardo, F., RUBAGOTTI, A., AMOROSO, D., Sismondi, P., Genta, F. T., Nenci, I., PIFFANELLI, A., Farris, A., CASTAGNETTA, L. A. M., Traina, A., et al. (1992) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80123-6 · Cited by 58
Absence of linkage to the ataxia telangiectasia locus in familial breast cancer
Wooster, R., Ford, D., Mangion, J., Ponder, B. A. J., Peto, J., Easton, D. F., & R-Stratton, M. (1993) · Human Genetics · doi:10.1007/bf00216153 · Cited by 58
Leukemia risk following radiotherapy for breast cancer.
Curtis, R. E., Boice, J. D., Stovall, M., Flannery, J., & Moloney, W. C. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.1.21 · Cited by 57
Diagnosis and management of brachial plexus lesions in cancer patients.
Sh, K. (1995) · PubMed · Cited by 57
Late effects of adjuvant therapy for breast cancer.
Shapiro, C. L., & Recht, A. (1994) · PubMed · Cited by 56
Self-citationLee, J. H., Glick, H. A., Hayman, J. A., & Solin, L. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.008 · Cited by 55
Self-citationKaufmann, M., Jonat, W., Abel, U. R., Hilfrich, J., Caffier, H., Kreienberg, R., Trams, G., Brunnert, K., Schermann, J., & Kleine, W. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.454 · Cited by 54
Lind, P., Gagliardi, G., Wennberg, B., & Fornander, T. (1997) · Acta Oncologica · doi:10.3109/02841869709001307 · Cited by 50
Dose to the Cardiac Vascular and Conduction Systems in Primary Breast Irradiation
Janjan, N. A., Gillin, M. T., Prows, J., et al. (1989) · Medical dosimetry · doi:10.1016/0958-3947(89)90176-3 · Cited by 39
Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed?
Helintö, M., BLOMQVIST, C. P., Heikkilä, P., et al. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00099-7 · Cited by 38
Tolerance of Radiotherapy Combined with Adjuvant Chemotherapy in Breast Cancer
Hrafnkelsson, J., Nilsson, K., & Söderberg, M. (1987) · Acta Oncologica · doi:10.3109/02841868709089973 · Cited by 12
Cited by
EBCTCG (Early Breast Cancer Trialists' Collaborative Group) (2014) · The Lancet · doi:10.1016/s0140-6736(14)60488-8 · Cited by 2,254
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Moran, M. S., Abraham, J., Aft, R., Agnese, D., Allison, K. H., Anderson, B., Burstein, H. J., Chew, H., Dang, C., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0030 · Cited by 951
Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm271 · Cited by 944
Kyndi, M., Sørensen, F. B., Knudsen, H., Overgaard, M., Nielsen, H. M., & Overgaard, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.5565 · Cited by 568
Metadata
- Authors
- Recht, A., Edge, S. B., Solin, L. J., Robinson, D. S., Estabrook, A., Fine, R. E., Fleming, G. F., Formenti, S., Hudis, C., Kirshner, J. J., Krause, D. A., Kuske, R. R., Langer, A. S., Sledge, G. W., Whelan, T. J., & Pfister, D. G.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-03-01
- Volume
- 19
- Issue
- 5
- Pages
- 1539-1569
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2122761438
- Cited by
- 816
- References
- 88
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.